Phase II trial of docetaxel (T), cisplatin (P) and fluorouracil (5-FU) in the treatment of metastatic penile cancer
Phase 2
Recruiting
- Conditions
- patients with metastatic penile cancer
- Registration Number
- JPRN-UMIN000002697
- Lead Sponsor
- Fudan University Shanghai Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Usage of experimental drugs 2) History of serious drug allergy or hypersensitivity with cisplatin or paclitaxel 3) Peripheral neuropathy 4) Ototoxicity 5) Uncontrolled infection 6) Double cancer 7) Coexisting severe medical conditions 8) Mental disease 9) Judged as inappropriate to participate this trial by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate, Toxicity
- Secondary Outcome Measures
Name Time Method Progression free survival, Quality of life